Publications by authors named "Toru Kodo"

Claim this Profile
E
Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer.
Sadanori Watanabe, Akitada Yogo, Tsuguteru Otsubo, Hiroki Umehara, Jun Oishi, Toru Kodo

BMC Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT weak partial agonistic activity showing the antidepressant-like effect.
Hidefumi Yoshinaga, Shuji Masumoto, Koji Koyama, Naoya Kinomura, Yuji Matsumoto, Toru Kodo

Bioorg Med Chem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and structure-activity relationship of novel tricyclic benzimidazolone derivatives as potent 18 kDa translocator protein (TSPO) ligands.
Takayuki Fukaya, Toru Kodo, Takeo Ishiyama, Hiroyuki Nishikawa, Satoko Baba

Bioorg Med Chem· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and structure-activity relationships of novel benzoxazolone derivatives as 18 kDa translocator protein (TSPO) ligands.
Takayuki Fukaya, Toru Kodo, Takeo Ishiyama, Hiroyoshi Kakuyama, Hiroyuki Nishikawa

Bioorg Med Chem· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor.
Seiji Katayama, Nobuyuki Ae, Toru Kodo, Shuji Masumoto, Shinji Hourai

J Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis